Recent Updates
Recently added Catalysts
ENOV Neutral Sentiment Score: 60/100

Enovis Announces Time Change for Second Quarter 2024 Results Conference Call

Key Takeaway: Enovis Corporation has announced a change in the timing of its second quarter 2024 earnings results conference call, moving it to 8:00 a.m. Eastern Time on August 7, 2024. The date remains unchanged, and all essential dial-in and webcasting information are still valid. This announcement reflects the company's ongoing commitment to keeping investors informed, as it routinely shares material information through various channels.

Market Sentiment Analysis

POSITIVE FACTORS

  • Enovis continues its commitment to transparency with timely announcements.
  • The change in time for the conference call is manageable with no impact on the date.
  • The company shows dedication to providing updated information through multiple channels.

Full Press Release Details

Wilmington, DE, July 25, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced a change in the scheduling of its upcoming earnings results conference call. The call will still take place on August 7, 2024, but will now be held at 8:00 a.m. Eastern Time, instead of the previously announced time. There is no change to the date, the dial-in or webcasting information. A presentation related to the call will be available on ir.enovis.com.
Conference call/Webcast Information
Investors can access the live webcast via a link on the Enovis website. For those planning to participate on the call, please dial (833) 685-0901 (U.S. callers) and (412) 317-5715 (International callers) and ask to join the Enovis call. A link to a replay of the call will also be available on the Enovis website later that day.
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company’s shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV.  For more information about Enovis, please visit www.enovis.com.
Availability of Information on the Enovis Website
Investors and others should note that Enovis routinely announces material information to investors and the marketplace using SEC filings, press releases, public conference calls, webcasts and the Enovis Investor Relations website. While not all of the information that the Company posts to the Enovis Investor Relations website is of a material nature, some information could be deemed to be material. Accordingly, the Company encourages investors, the media and others interested in Enovis to review the information that it shares on ir.enovis.com.
Vice President, Investor Relations

Frequently Asked Questions

When is the Enovis earnings conference call scheduled?

The Enovis earnings conference call is on August 7, 2024, at 8:00 a.m. Eastern Time.

How can I access the Enovis conference call?

You can access the Enovis conference call by dialing (833) 685-0901 for U.S. callers.

Where can I find the presentation for the Enovis call?

The presentation related to the Enovis call will be available on ir.enovis.com.

What is the stock symbol for Enovis Corporation?

Enovis Corporation's stock symbol is ENOV on the New York Stock Exchange.

How does Enovis share material information?

Enovis shares material information through SEC filings, press releases, and webcasts.

Last updated: Jul 25, 2024